• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠细胞提取物中反义寡脱氧核苷酸对天然RNA可及性的快速测定与定量分析

Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts.

作者信息

Scherr M, Rossi J J

机构信息

Department of Molecular Biology, Beckman Research Institute of the City of Hope, 1450 East Duarte Road, Duarte, CA 91010-3011, USA.

出版信息

Nucleic Acids Res. 1998 Nov 15;26(22):5079-85. doi: 10.1093/nar/26.22.5079.

DOI:10.1093/nar/26.22.5079
PMID:9801303
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC147980/
Abstract

A major concern for antisense experiments is the prediction of effective oligonucleotide binding sites. We have developed a system to carry out oligodeoxyribonucleotide-RNA and ribozyme-RNA binding experiments in cell extracts to create a protein environment known to directly influence the structure of the mRNA. In these experiments the native, endogenous mRNA is probed using oligodeoxyribonucleotides (ODNs) to identify RNase H-accessible sites. The resulting RNase H-mediated cleavages in the cell extracts were quantified using RT-PCR with fluorescein and rhodaminetagged primers to generate fluorescent products that are analyzed and quantified on an automated DNA sequencer. As a model substrate for testing this system, we have targeted the murine DNA methyltransferase (MTase) mRNA. An ODN binding site in native MTase mRNA was identified that was cleaved by endogenous RNase H with an efficiency of 85% in the extracts. The ODN that was most effective in the cell extracts was also found to provide the best activity in vivo , resulting in a 75-85% reduction of the MTase mRNA. These data support the use of cell extracts and native transcripts to identify antisense and perhaps ribozyme target sites.

摘要

反义实验的一个主要问题是有效寡核苷酸结合位点的预测。我们开发了一个系统,用于在细胞提取物中进行寡脱氧核糖核苷酸-RNA和核酶-RNA结合实验,以营造一种已知会直接影响mRNA结构的蛋白质环境。在这些实验中,使用寡脱氧核糖核苷酸(ODN)探测天然的内源性mRNA,以识别可被核糖核酸酶H作用的位点。细胞提取物中核糖核酸酶H介导的切割产物,通过使用荧光素和罗丹明标记的引物进行逆转录聚合酶链反应(RT-PCR)进行定量,以生成荧光产物,并在自动DNA测序仪上进行分析和定量。作为测试该系统的模型底物,我们选择了小鼠DNA甲基转移酶(MTase)mRNA。在天然MTase mRNA中鉴定出一个ODN结合位点,该位点在提取物中被内源性核糖核酸酶H切割,切割效率为85%。在细胞提取物中最有效的ODN在体内也具有最佳活性,导致MTase mRNA减少75-85%。这些数据支持使用细胞提取物和天然转录本来鉴定反义以及可能的核酶靶位点。

相似文献

1
Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts.小鼠细胞提取物中反义寡脱氧核苷酸对天然RNA可及性的快速测定与定量分析
Nucleic Acids Res. 1998 Nov 15;26(22):5079-85. doi: 10.1093/nar/26.22.5079.
2
Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.天然mRNA上反义及核酶可及位点的检测:应用于NCOA3 mRNA
Mol Ther. 2001 Nov;4(5):454-60. doi: 10.1006/mthe.2001.0481.
3
RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts.RNA可及性预测:一种理论方法与细胞提取物中的实验研究一致。
Nucleic Acids Res. 2000 Jul 1;28(13):2455-61. doi: 10.1093/nar/28.13.2455.
4
Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.提取物中天然mRNA的寡核苷酸扫描可预测细胞内核酶效率:核酶介导的小鼠DNA甲基转移酶的减少。
Mol Ther. 2000 Jul;2(1):26-38. doi: 10.1006/mthe.2000.0091.
5
Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.针对谷胱甘肽S-转移酶Mu的反义寡脱氧核苷酸的筛选
RNA. 2002 Dec;8(12):1572-83.
6
Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA.反义寡脱氧核苷酸与结构化信使核糖核酸结合的热力学和动力学特征
Biophys J. 2002 Jan;82(1 Pt 1):366-77. doi: 10.1016/S0006-3495(02)75401-5.
7
Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes.作为核酶靶位点选择工具的mRNA二级结构预测及体外可及性
Nucleic Acids Res. 2000 Nov 1;28(21):4113-24. doi: 10.1093/nar/28.21.4113.
8
Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo.通过与扫描阵列杂交筛选出的反义寡核苷酸是有效的体内试剂。
Nucleic Acids Res. 2001 May 15;29(10):2041-51. doi: 10.1093/nar/29.10.2041.
9
Antisense oligodeoxynucleotide and ribozyme design.反义寡脱氧核苷酸和核酶设计
Methods. 2000 Nov;22(3):271-81. doi: 10.1006/meth.2000.1079.
10
Determination of potent antisense oligonucleotides in vitro by semiempirical rules.
J Biosci Bioeng. 2007 Mar;103(3):270-7. doi: 10.1263/jbb.103.270.

引用本文的文献

1
Enhanced hammerhead ribozyme turnover rates: Reevaluating therapeutic space for small catalytic RNAs.增强型锤头状核酶的周转速率:重新评估小型催化RNA的治疗空间。
Mol Ther Nucleic Acids. 2024 Dec 21;36(1):102431. doi: 10.1016/j.omtn.2024.102431. eCollection 2025 Mar 11.
2
Systematic Screening, Rational Development, and Initial Optimization of Efficacious RNA Silencing Agents for Human Rod Opsin Therapeutics.用于人类视杆视蛋白治疗的有效RNA沉默剂的系统筛选、合理开发及初步优化
Transl Vis Sci Technol. 2019 Dec 12;8(6):28. doi: 10.1167/tvst.8.6.28. eCollection 2019 Nov.
3
A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets.一种针对治疗性反式切割核酶和针对任意mRNA疾病靶点的RNA干扰的细胞高通量筛选方法。
Exp Eye Res. 2016 Oct;151:236-55. doi: 10.1016/j.exer.2016.05.020. Epub 2016 May 25.
4
Variables and strategies in development of therapeutic post-transcriptional gene silencing agents.治疗性转录后基因沉默剂开发中的变量与策略
J Ophthalmol. 2011;2011:531380. doi: 10.1155/2011/531380. Epub 2011 Jun 30.
5
Improvement of RNA secondary structure prediction using RNase H cleavage and randomized oligonucleotides.利用核糖核酸酶H切割和随机寡核苷酸改进RNA二级结构预测
Nucleic Acids Res. 2009 Oct;37(18):e121. doi: 10.1093/nar/gkp587. Epub 2009 Jul 13.
6
Development of lead hammerhead ribozyme candidates against human rod opsin mRNA for retinal degeneration therapy.开发针对人视杆细胞视蛋白mRNA的锤头状核酶候选物用于视网膜变性治疗。
Exp Eye Res. 2009 May;88(5):859-79. doi: 10.1016/j.exer.2008.11.018. Epub 2008 Dec 6.
7
Bottlenecks in development of retinal therapeutic post-transcriptional gene silencing agents.视网膜治疗性转录后基因沉默剂开发中的瓶颈
Vision Res. 2008 Feb;48(3):453-69. doi: 10.1016/j.visres.2007.09.011. Epub 2007 Oct 31.
8
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition.直击中心法则的核心:序列特异性抑制。
Microb Cell Fact. 2007 Aug 10;6:24. doi: 10.1186/1475-2859-6-24.
9
Antiviral applications of RNAi.RNA干扰的抗病毒应用。
Handb Exp Pharmacol. 2006;173(173):105-16. doi: 10.1007/3-540-27262-3_6.
10
Lentiviral-mediated delivery of siRNAs for antiviral therapy.慢病毒介导的小干扰RNA递送用于抗病毒治疗。
Gene Ther. 2006 Mar;13(6):553-8. doi: 10.1038/sj.gt.3302688.